GE HealthCare Technologies Inc has a consensus price target of $94.38 based on the ratings of 16 analysts. The high is $110 issued by Argus Research on April 1, 2024. The low is $80 issued by Jefferies on November 30, 2023. The 3 most-recent analyst ratings were released by Goldman Sachs, B of A Securities, and Mizuho on May 30, 2024, May 1, 2024, and May 1, 2024, respectively. With an average price target of $92.67 between Goldman Sachs, B of A Securities, and Mizuho, there's an implied 15.20% upside for GE HealthCare Technologies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/30/2024 | Buy Now | 8.16% | Goldman Sachs | David Roman | → $87 | Initiates | → Neutral | Get Alert |
05/01/2024 | Buy Now | 6.91% | B of A Securities | Craig Bijou | $94 → $86 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 30.53% | Mizuho | Anthony Petrone | $110 → $105 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 36.75% | Mizuho | Anthony Petrone | $96 → $110 | Maintains | Buy | Get Alert |
04/04/2024 | Buy Now | 24.32% | Evercore ISI Group | Vijay Kumar | $93 → $100 | Maintains | Outperform | Get Alert |
04/03/2024 | Buy Now | 28.05% | Citigroup | Joanne Wuensch | $88 → $103 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 36.75% | Argus Research | David Toung | $80 → $110 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | 24.32% | HSBC | Sezgi Oezener | → $100 | Initiates | → Buy | Get Alert |
02/12/2024 | Buy Now | 6.91% | Morgan Stanley | Patrick Wood | $74 → $86 | Maintains | Equal-Weight | Get Alert |
02/12/2024 | Buy Now | 9.4% | UBS | Graham Doyle | $66 → $88 | Upgrade | Sell → Neutral | Get Alert |
02/07/2024 | Buy Now | 19.34% | Mizuho | Anthony Petrone | $94 → $96 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | -8.01% | Morgan Stanley | Patrick Wood | $78 → $74 | Maintains | Equal-Weight | Get Alert |
11/30/2023 | Buy Now | -0.55% | Jefferies | Matthew Taylor | → $80 | Initiates | → Hold | Get Alert |
11/27/2023 | Buy Now | -17.95% | UBS | Graham Doyle | $86 → $66 | Downgrade | Neutral → Sell | Get Alert |
09/19/2023 | Buy Now | 1.94% | Citigroup | Joanne Wuensch | → $82 | Initiates | → Buy | Get Alert |
08/16/2023 | Buy Now | 11.88% | Wells Fargo | Larry Biegelsen | → $90 | Initiates | → Overweight | Get Alert |
07/31/2023 | Buy Now | 1.94% | B of A Securities | Craig Bijou | → $82 | Initiates | → Neutral | Get Alert |
07/26/2023 | Buy Now | -3.03% | Morgan Stanley | Patrick Wood | $76 → $78 | Maintains | Equal-Weight | Get Alert |
06/28/2023 | Buy Now | -5.52% | Morgan Stanley | Patrick Wood | → $76 | Initiates | → Equal-Weight | Get Alert |
06/27/2023 | Buy Now | -5.52% | Morgan Stanley | Patrick Wood | → $76 | Initiates | → Equal-Weight | Get Alert |
05/16/2023 | Buy Now | 20.59% | Oppenheimer | Suraj Kalia | → $97 | Initiates | → Outperform | Get Alert |
04/26/2023 | Buy Now | 16.86% | Mizuho | Anthony Petrone | $92 → $94 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 6.91% | UBS | Graham Doyle | → $86 | Initiates | → Neutral | Get Alert |
04/19/2023 | Buy Now | 18.1% | Piper Sandler | Jason Bednar | → $95 | Initiates | → Overweight | Get Alert |
04/18/2023 | Buy Now | 14.37% | Mizuho | Anthony Petrone | $90 → $92 | Maintains | Buy | Get Alert |
04/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman | — | Initiates | → Neutral | Get Alert |
03/13/2023 | Buy Now | 11.88% | Evercore ISI Group | Vijay Kumar | → $90 | Initiates | → Outperform | Get Alert |
02/17/2023 | Buy Now | 11.88% | Mizuho | Anthony Petrone | → $90 | Initiates | → Buy | Get Alert |
01/19/2023 | Buy Now | — | Redburn Partners | Ed Ridley-Day | — | Initiates | → Buy | Get Alert |
01/04/2023 | Buy Now | — | Edward Jones | John Boylan | — | Initiates | → Hold | Get Alert |
The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Goldman Sachs on May 30, 2024. The analyst firm set a price target for $87.00 expecting GEHC to rise to within 12 months (a possible 8.16% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Goldman Sachs, and GE HealthCare Techs initiated their neutral rating.
The last upgrade for GE HealthCare Technologies Inc happened on February 12, 2024 when UBS raised their price target to $88. UBS previously had a sell for GE HealthCare Technologies Inc.
The last downgrade for GE HealthCare Technologies Inc happened on November 27, 2023 when UBS changed their price target from $86 to $66 for GE HealthCare Technologies Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.
While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a initiated with a price target of $0.00 to $87.00. The current price GE HealthCare Techs (GEHC) is trading at is $80.44, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.